Public Profile

Galderma International S.A.S

Galderma International S.A.S., headquartered in France, is a leading global player in the dermatology and aesthetic medicine industry. Founded in 1981, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. Galderma is renowned for its innovative products and services, focusing on skin health, medical dermatology, and aesthetic solutions. Its core offerings include the popular Restylane® range of dermal fillers and the Sculptra® collagen-stimulating injectable, both of which are distinguished by their unique formulations and proven efficacy. With a commitment to advancing dermatological science, Galderma has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and patients alike. The company continues to lead the market with its dedication to research and development, ensuring it remains at the forefront of the industry.

DitchCarbon Score

How does Galderma International S.A.S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Galderma International S.A.S's score of 26 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Galderma International S.A.S's reported carbon emissions

Galderma International S.A.S, headquartered in France, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its environmental impact. As the industry increasingly prioritises sustainability, it will be important for Galderma to establish clear emissions reduction goals and strategies to align with global climate standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Galderma International S.A.S's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Galderma International S.A.S is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Galderma International S.A.S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Merz Pharmaceuticals GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

SciVision Biotech Inc.

TW
Health and social work services (85)
Updated 4 days ago

Allergan, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers